Disc Medicine, Inc. - IRON Earnings per share for the last twelve months

Official company branding of Disc Medicine Pharma (IRON)

Disc Medicine, Inc. (IRON) specialization in the therapy of rare blood pathologies ensures long-term financial stability. Current earnings per share over the last 12 months demonstrate a recovery trend, where the -6.32 mark characterizes this parameter. Business efficiency is bolstered by the implementation of robotic cell screening, although high dependence on external contract research organizations remains a key operational risk.

IRON Disc Medicine Pharma Net earnings per one share for the last twelve months (04/28/2023 - 11/17/2026)

Financial and market metric breakdowns for Disc Medicine Corp (IRON)

- current quotes and average value forecast:
Fundamental company analysis:IRON - Disc Medicine Inc
Manufactured products of Disc Medicine Inc

Exclusive patents and stringent FDA oversight create high barriers to entry for Disc Medicine, Inc. (IRON), transforming R&D expenditures into the primary driver of profitability. By analyzing the company's TTM EPS dynamics, an investor assesses the actual concentration of profit per share over the year, where a lack of volatility in the trend line may signal business stagnation despite the regulatory protection of assets.